Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples